sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Calcium Channel Blocker Market by Drug class (Dihydropyridine and Non-Dihydropyridine) for Hypertension, Angina Pectoris, Pregnancy, Obesity and Other - Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Calcium Channel Blocker Market by Drug class (Dihydropyridine and Non-Dihydropyridine)...

Home / Categories / Healthcare
Calcium Channel Blocker Market by Drug class (Dihydropyridine and Non-Dihydropyridine) for Hypertension, Angina Pectoris, Pregnancy, Obesity and Other - Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022
Calcium Channel Blocker Market by...
Report Code
RO1/106/1001

Publish Date
10/Jan/2017

Pages
110
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..

Chapter 1. Introduction


1.1. Report Description And Scope

1.2. Research Scope

1.3. Research Methodology


1.3.1. Market Research Process

1.3.2. Market Research Methodology

Chapter 2. Executive Summary


2.1. Global Calcium Channel Blocker Market, 2016 - 2022 (USD Million)

2.2. Global Calcium Channel Blocker Market: Snapshot

Chapter 3. Calcium Channel Blocker  Market Dynamics


3.1. Introduction

3.2. Value Chain Analysis

3.3. Market Drivers


3.3.1. Global Calcium Channel Blocker Market Drivers: Impact Analysis

3.3.2. Rising prevalence of Hypertension.

3.3.3. Growth percentage of Obesity.

3.4. Market Restraints


3.4.1. Global Calcium Channel Blocker Market Restraints: Impact Analysis

3.4.2. Adverse Effect of Drug.

3.5. Opportunities


3.5.1. Combination Therapy of CCB Drugs

3.6. Porters Five Forces Analysis


3.6.1. Bargaining Power Of Suppliers

3.6.2. Bargaining Power Of Buyers

3.6.3. Threat From New Entrants

3.6.4. Threat From New Substitutes

3.6.5. Degree Of Competition

3.7. Market Attractiveness Analysis


3.7.1. Market Attractiveness Analysis, By Drug Class Segment

3.7.2. Market Attractiveness Analysis, By Application Segment

3.7.3. Market Attractiveness Analysis, By Regional Segment

Chapter 4. Global Calcium Channel Blocker Market  Competitive Landscape


4.1. Company Market Share, 2016 (Subject To Data Availability)

4.2. Strategic Development


4.2.1. Acquisitions  Mergers

4.2.2. New Product Launch

4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures

4.2.4. Research And Development, Product And Regional Expansion

4.3. Product Portfolio

Chapter 5. Global Calcium Channel Blocker Market  Drug Class Segment Analysis


5.1. Global Calcium Channel Blocker Market: Drug Class Segment Overview


5.1.1. Global Calcium Channel Blocker Market Revenue Share, By Drug Class Segment, 2016 And 2022

5.2. Dihydropyridine


5.2.1. Global Dihydropyridine Market, 2016  2022 (USD Million)

5.2.2. Amlodipine


5.2.2.1. Calcium Channel Blocker Market Revenue for Amlodipine , 2016  2022 (USD Million)

5.2.3. Cilnidipine


5.2.3.1. Calcium Channel Blocker Market Revenue for Cilnidipine , 2016  2022 (USD Million)

5.2.4. Felodipine


5.2.4.1. Calcium Channel Blocker Market Revenue for Felodipine , 2016  2022 (USD Million)

5.2.5. Isradipine


5.2.5.1. Calcium Channel Blocker Market Revenue for Isradipine , 2016  2022 (USD Million)

5.2.6. Nicardipine


5.2.6.1. Calcium Channel Blocker Market Revenue for Nicardipine , 2016  2022 (USD Million)

5.2.7. Nisoldipine


5.2.7.1. Calcium Channel Blocker Market Revenue for Nisoldipine , 2016  2022 (USD Million)

5.2.8. Nifedipine


5.2.8.1. Calcium Channel Blocker Market Revenue for Nifedipine , 2016  2022 (USD Million)

5.2.9. Others


5.2.9.1. Calcium Channel Blocker Market Revenue for Others , 2016  2022 (USD Million)

5.3. Non-Dihydropyridine


5.3.1. Global Non-Dihydropyridine Market, 2016  2022 (USD Million)

5.3.2. Diltiazem


5.3.2.1. Calcium Channel Blocker Market Revenue for Diltiazem , 2016  2022 (USD Million)

5.3.3. Verapamil


5.3.3.1. Calcium Channel Blocker Market Revenue for Verapamil , 2016  2022 (USD Million)


Chapter 6. Global Calcium Channel Blocker Market  Application Segment Analysis


6.1. Global Calcium Channel Blocker Market: Application Segment Overview


6.1.1. Global Calcium Channel Blocker Market Revenue Share, By Application Segment, 2016 And 2022

6.2. Angina Pectoris


6.2.1. Global Calcium Channel Blocker Market For Angina Pectoris, 2016  2022 (USD Million)

6.3. Hypertension


6.3.1. Global Calcium Channel Blocker Market For Hypertension, 2016  2022 (USD Million)

6.4. Pregnancy


6.4.1. Global Calcium Channel Blocker Market For Pregnancy, 2016  2022 (USD Million)

6.5. Obesity


6.5.1. Global Calcium Channel Blocker Market For Obesity, 2016  2022 (USD Million)

6.6. Others


6.6.1. Global Calcium Channel Blocker Market For Others, 2016  2022 (USD Million)

Chapter 7. Global Calcium Channel Blocker Market  Regional Segment Analysis


7.1. Global Calcium Channel Blocker Market: Regional Overview


7.1.1. Global Calcium Channel Blocker Market Revenue Share, By Region, 2016 And 2022

7.2. North America


7.2.1. North America Calcium Channel Blocker Market Revenue, By Drug Class , 2016  2022 , (USD Million)

7.2.2. North America Calcium Channel Blocker Market Revenue, By Application, 2016  2022 , (USD Million)

7.3. Europe


7.3.1. Europe Calcium Channel Blocker Market Revenue, By Drug Class , 2016  2022 (USD Million)

7.3.2. Europe Calcium Channel Blocker Market Revenue, By Application, 2016  2022 (USD Million)

7.4. Asia Pacific


7.4.1. Asia Pacific Calcium Channel Blocker Market Revenue, By Drug Class , 2016  2022 (USD Million)

7.4.2. Asia Pacific Calcium Channel Blocker Market Revenue, By Application, 2016  2022 (USD Million)

7.5. Latin America


7.5.1. Latin America Calcium Channel Blocker Market Revenue, By Drug Class , 2016  2022 (USD Million)

7.5.2. Latin America Calcium Channel Blocker Market Revenue, By Application, 2016  2022 (USD Million)

7.6. Middle East And Africa


7.6.1. Middle East And Africa Calcium Channel Blocker Market Revenue, By Drug Class , 2016  2022 (USD Million)

7.6.2. Middle East And Africa Calcium Channel Blocker Market Revenue, By Application, 2016  2022 (USD Million)

Chapter 8. Company Profile


8.1. Pfizer Inc.,


8.1.1. Overview

8.1.2. Financials

8.1.3. Product Portfolio

8.1.4. Business Strategy

8.1.5. Recent Developments

8.2. AstraZeneca plc.,


8.2.1. Overview

8.2.2. Financials

8.2.3. Product Portfolio

8.2.4. Business Strategy

8.2.5. Recent Developments

8.3. Bayer Healthcare LLC.


8.3.1. Overview

8.3.2. Financials

8.3.3. Product Portfolio

8.3.4. Business Strategy

8.3.5. Recent Developments

8.4. GlaxoSmithKline plc


8.4.1. Overview

8.4.2. Financials

8.4.3. Product Portfolio

8.4.4. Business Strategy

8.4.5. Recent Developments

8.5. Sanofi S.A.


8.5.1. Overview

8.5.2. Financials

8.5.3. Product Portfolio

8.5.4. Business Strategy

8.5.5. Recent Developments

8.6. Johnson  Johnson


8.6.1. Overview

8.6.2. Financials

8.6.3. Product Portfolio

8.6.4. Business Strategy

8.6.5. Recent Developments

8.7. Abcam


8.7.1. Overview

8.7.2. Financials

8.7.3. Product Portfolio

8.7.4. Business Strategy

8.7.5. Recent Developments

8.8. AbMole Bioscience


8.8.1. Overview

8.8.2. Financials

8.8.3. Product Portfolio

8.8.4. Business Strategy

8.8.5. Recent Developments

8.9. Clearsynth


8.9.1. Overview

8.9.2. Financials

8.9.3. Product Portfolio

8.9.4. Business Strategy

8.9.5. Recent Developments

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com